ANI PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

05 май 2025 09:52:17 Источник NetDania Notify

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

05 май 2025 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

02 май 2025 13:34:23 Источник NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

29 апр 2025 12:06:34 Источник NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

28 апр 2025 09:46:14 Источник NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

25 апр 2025 13:49:24 Источник NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

17 апр 2025 15:49:11 Источник NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

16 апр 2025 11:51:13 Источник NetDania Notify

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

09 апр 2025 06:50:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

31 мар 2025 16:30:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

19 мар 2025 06:50:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

18 мар 2025 06:50:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

14 мар 2025 06:50:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

03 мар 2025 16:30:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

28 фев 2025 06:50:16 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 фев 2025 16:30:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 янв 2025 16:30:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 янв 2025 06:50:00 Источник Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 янв 2025 06:50:00 Источник Nasdaq GlobeNewswire